Stay updated on Upadacitinib vs Placebo in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA Clinical Trial page
- Check4 days agoChange DetectedThe Rheumatoid arthritis topic and the related MedlinePlus Genetics section have been removed from the page. This reduces visible disease-context on the study details page and may affect how users access disease-specific information.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing v3.3.1. This appears to be a minor system update with no changes to the study content or functionality.SummaryDifference0.0%

- Check25 days agoChange DetectedPubMed publications note updated to indicate automatic filling from PubMed and that articles may not be about the study, and the revision label changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check33 days agoChange DetectedRheumatoid arthritis and related topics: MedlinePlus Genetics were added to the page, and a generic government funding notice about operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check40 days agoChange DetectedRheumatoid arthritis and the related topic MedlinePlus Genetics were removed from the page's related topics section. This reduces disease-context navigation for readers.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now includes Related Topics: Rheumatoid arthritis and MedlinePlus Genetics to provide additional context and navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Upadacitinib vs Placebo in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.